Being Health, a startup that launched last week, offers a care team that includes psychiatrists, psychotherapists, nurse anesthetists, functional medicine physicians, nutritionists, acupuncturists and care advocates. It serves patients both virtually and in person.
Malla, a startup that launched Wednesday, is trying to make functional, personalized medicine more accessible. Consumers can purchase a membership, which includes one-on-one video sessions with a practitioner, messaging, personalized care plans and tracking.
Override provides chronic pain patients with a care team that includes a pain physician, a physical therapist, a psychologist and a coach. The company has received $3.5 million in seed funding and has acquired Take Courage Coaching.
Though the Medicare Advantage-focused insurance technology startup is smaller than rivals like Clover Health in terms of membership and revenues, this latest financing round places it ahead of, or at least on par with, several larger competitors with regard to total funds raised.
Diagnostics startup GRIP Molecular is developing an at-home test for Covid-19 and other respiratory infections. The technology builds on advances from several fields, including the discovery of graphene, a material that offers biocompatibility and conductivity.
Frank Westermann sold his previous startup, mySugr, to Roche four years ago. Now, he’s starting a new company with the goal of making healthcare providers and diabetes medications more accessible.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Anil Sethi was the director of health records at Apple until his sister was diagnosed with metastatic breast cancer, and given weeks to live. After traveling with her to different doctors across the country, and helping carry her records, Sethi created his own company to pull together harder-to-find records, such as scans and pathology reports.
Cigna Ventures and Blue Shield of California contributed to a funding round for Cricket Health, a startup that provides services to help patients identify chronic kidney disease and get support in treatment. The investment was led by Valtruis, a firm that invests in value-based care companies.
DrChrono, one of the first companies to build out a mobile-friendly EHR, raised $12 million in funding. The startup plans to use the funds to build out its telehealth platform.
Five Blue Cross Blue Shield plans provided funding to establish Evio, which aims to improve clinical outcomes and cut drug costs. It will initially only offer services to the founding health plans, including data analytics to determine drug performance and enhancing outcomes-based contracting.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
AllyAlign Health, which offers health plans for seniors like Medicare Advantage and institutional special needs plans, has raised $300 million in funding. It will use the funds to scale its business.
The system, developed by digital health startup Cognoa, uses information from questionnaires and videos to help pediatricians diagnose autism. It received marketing authorization from the FDA on Wednesday.
Medication adherence startup PillDrill is suing a digital health company UpHealth, claiming it lied about plans to acquire the startup as part of a broader SPAC deal.
Leaps by Bayer led a $90 million investment round into Ada, a German digital health startup with an AI-based symptom checker. As part of the deal, the two companies are also striking a broader strategic partnership.
Curebase, a startup building software for decentralized clinical trials, raised $15 million in funding. The startup ran six trials related to Covid-19 in the last year.
